Evidence map›Paper›PMID 26626734›Full record

ArticleBMC genomics2015

Fusion transcript loci share many genomic features with non-fusion loci.

John Lai, Jiyuan An, Inge Seim, Carina Walpole, Andrea Hoffman, Leire Moya, Srilakshmi Srinivasan, Joanna L Perry-Keene, Australian Prostate Cancer Bioresource, Chenwei Wang and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Molecular Signatures of Fusion Proteins in Cancer.ACS pharmacology & translational science · 2019
    Article
  4. Genome-wide colocalization of RNA-DNA interactions and fusion RNA pairs.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  5. Review
  6. Article
  7. Chimeric RNAs and their implications in cancer.Current opinion in genetics & development · 2018
    Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

John LaiAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. j2.lai@qut.edu.au.
Jiyuan AnAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. J.an@qut.edu.au.
Inge SeimAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. i.seim@qut.edu.au.
Carina WalpoleAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. c.walpole@qut.edu.au.
Andrea HoffmanAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. andrea.hoffman@qut.edu.au.
Leire MoyaAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. leire.moya@qut.edu.au.
Srilakshmi SrinivasanAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. srilakshmi.srinivasan@qut.edu.au.
Joanna L Perry-KeeneAnatomical Pathology, Pathology Queensland, Brisbane, Australia. Joanna_PerryKeene@health.qld.gov.au.
Australian Prostate Cancer Bioresource
Chenwei WangAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. chenwei.wang@qut.edu.au.
Melanie L LehmanAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. melanie.lehman@qut.edu.au.
Colleen C NelsonAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. colleen.nelson@qut.edu.au.
Judith A ClementsAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. j.clements@qut.edu.au.
Jyotsna BatraAustralian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Brisbane, Australia. jyotsna.batra@qut.edu.au.
Translational Research Institute · AUQueensland Health · AUQueensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFusion transcripts are found in many tissues and have the potential to create novel functional products. Here, we investigate the genomic sequences around fusion junctions to better understand the transcriptional mechanisms mediating fusion transcription/splicing. We analyzed data from prostate (cancer) cells as previous studies have shown extensively that these cells readily undergo fusion transcription.

resultsWe used the FusionMap program to identify high-confidence fusion transcripts from RNAseq data. The RNAseq datasets were from our (N = 8) and other (N = 14) clinical prostate tumors with adjacent non-cancer cells, and from the LNCaP prostate cancer cell line that were mock-, androgen- (DHT), and anti-androgen- (bicalutamide, enzalutamide) treated. In total, 185 fusion transcripts were identified from all RNAseq datasets. The majority (76%) of these fusion transcripts were 'read-through chimeras' derived from adjacent genes in the genome. Characterization of sequences at fusion loci were carried out using a combination of the FusionMap program, custom Perl scripts, and the RNAfold program. Our computational analysis indicated that most fusion junctions (76%) use the consensus GT-AG intron donor-acceptor splice site, and most fusion transcripts (85%) maintained the open reading frame. We assessed whether parental genes of fusion transcripts have the potential to form complementary base pairing between parental genes which might bring them into physical proximity. Our computational analysis of sequences flanking fusion junctions at parental loci indicate that these loci have a similar propensity as non-fusion loci to hybridize. The abundance of repetitive sequences at fusion and non-fusion loci was also investigated given that SINE repeats are involved in aberrant gene transcription. We found few instances of repetitive sequences at both fusion and non-fusion junctions. Finally, RT-qPCR was performed on RNA from both clinical prostate tumors and adjacent non-cancer cells (N = 7), and LNCaP cells treated as above to validate the expression of seven fusion transcripts and their respective parental genes. We reveal that fusion transcript expression is similar to the expression of parental genes.

conclusionsFusion transcripts maintain the open reading frame, and likely use the same transcriptional machinery as non-fusion transcripts as they share many genomic features at splice/fusion junctions.

Indexed as

Gene Expression Regulation, NeoplasticQuantitative Trait LociRNA SplicingTranscription, GeneticAndrogensAntineoplastic Agents, HormonalComputational BiologyConserved SequenceDatasets as TopicHigh-Throughput Nucleotide SequencingHumansMaleNucleotide MotifsProstatic NeoplasmsRepetitive Sequences, Nucleic AcidRNA Splice SitesAndrogensAntineoplastic Agents, HormonalRNA Splice Sites

Identifiers

PMID26626734
PMCPMC4667522
OpenAlexW2185602829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.